IOL Chemicals And Pharmaceuticals, 524164, IOLCP Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,646.40
15.83
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,549.16
1.43%
1.12

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

16.32
17.30
4.86

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.15
16.48
-14.89

PAT CAGR (%)

10 Years
5 Years
3 Years

59.14
43.00
-22.89

P:E (Median)

8 Years
5 Years
3 Years

8.89
9.61
9.80

P:BV (Average)

8 Years
5 Years
3 Years

2.53
2.53
2.55

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.36
5.92
6.32

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 523.48 555.14 -5.70% 541.41 537.88 0.66% 565.01 518.51 8.97% 572.49 460.38 24.35%
Expenses 480.44 495.93 -3.12% 509.74 494.08 3.17% 508.99 408.36 24.64% 529.37 349.21 51.59%
EBITDA 43.04 59.21 -27.31% 31.67 43.80 -27.69% 56.02 110.15 -49.14% 43.12 111.17 -61.21%
EBIDTM 8.22% 10.67% 5.85% 8.14% 9.91% 21.24% 7.53% 24.15%
Other Income 6.64 8.88 -25.23% 5.06 10.51 -51.86% 5.15 5.72 -9.97% 6.93 6.21 11.59%
Interest 4.70 2.29 105.24% 3.51 1.89 85.71% 3.38 1.77 90.96% 2.34 1.44 62.50%
Depreciation 11.73 11.13 5.39% 11.32 10.80 4.81% 10.98 10.32 6.40% 11.01 9.97 10.43%
PBT 33.25 54.67 -39.18% 21.90 41.62 -47.38% 46.81 89.85 -47.90% 36.70 105.97 -65.37%
Tax 9.10 14.60 -37.67% 6.23 10.78 -42.21% 11.92 22.85 -47.83% 8.95 30.72 -70.87%
PAT 24.15 40.07 -39.73% 15.67 30.84 -49.19% 34.89 67.00 -47.93% 27.75 75.25 -63.12%
PATM 4.61% 7.22% 2.89% 5.73% 6.18% 12.92% 4.85% 16.35%
EPS 4.11 6.83 -39.82% 2.67 5.25 -49.14% 5.94 11.41 -47.94% 4.73 12.82 -63.10%

Description Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var% Mar 22 Mar 21 Var%
Net Sales 523.48 0.00 0 541.41 0.00 0 565.01 0.00 0 572.49 0.00 0
Expenses 480.79 0.00 0 509.51 0.00 0 509.22 0.00 0 527.36 0.00 0
EBITDA 42.69 0.00 0 31.90 0.00 0 55.79 0.00 0 45.13 0.00 0
EBIDTM 8.15% 0.00% 5.89% 0.00% 9.87% 0.00% 7.88% 0.00%
Other Income 6.65 0.00 0 5.07 0.00 0 5.16 0.00 0 6.93 0.00 0
Interest 4.70 0.00 0 3.51 0.00 0 3.38 0.00 0 2.34 0.00 0
Depreciation 11.75 0.00 0 11.32 0.00 0 10.98 0.00 0 11.01 0.00 0
PBT 32.89 0.00 0 22.14 0.00 0 46.59 0.00 0 38.71 0.00 0
Tax 9.10 0.00 0 6.23 0.00 0 11.92 0.00 0 8.95 0.00 0
PAT 23.79 0.00 0 15.91 0.00 0 34.67 0.00 0 29.76 0.00 0
PATM 4.54% 0.00% 2.94% 0.00% 6.14% 0.00% 5.20% 0.00%
EPS 4.05 0.00 0 2.71 0.00 0 5.91 0.00 0 5.07 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 2,202.39 2,184.02 1,966.98 1,894.47 1,685.33 983.30 710.65 580.42 384.73 563.50 481.51 Net Sales Growth 6.30% 11.03% 3.83% 12.41% 71.40% 38.37% 22.44% 50.86% -31.72% 17.03% Cost Of Goods Sold 1,598.15 1,570.51 1,102.84 1,065.01 1,047.25 695.28 477.40 416.20 279.34 369.54 300.23 Gross Profit 604.24 613.51 864.14 829.46 638.08 288.02 233.25 164.21 105.38 193.97 181.28 GP Margin 27.44% 28.09% 43.93% 43.78% 37.86% 29.29% 32.82% 28.29% 27.39% 34.42% 37.65% Total Expenditure 2,028.54 1,927.74 1,375.14 1,320.59 1,275.68 863.77 608.45 529.04 373.46 467.75 392.47 Power & Fuel Cost - 78.18 51.46 65.12 63.94 45.66 37.45 46.57 48.58 45.27 45.12 % Of Sales - 3.58% 2.62% 3.44% 3.79% 4.64% 5.27% 8.02% 12.63% 8.03% 9.37% Employee Cost - 141.30 115.55 97.20 78.43 56.10 43.18 35.13 24.72 27.08 22.08 % Of Sales - 6.47% 5.87% 5.13% 4.65% 5.71% 6.08% 6.05% 6.43% 4.81% 4.59% Manufacturing Exp. - 36.86 28.13 28.37 25.68 22.57 16.77 8.83 4.55 6.46 7.95 % Of Sales - 1.69% 1.43% 1.50% 1.52% 2.30% 2.36% 1.52% 1.18% 1.15% 1.65% General & Admin Exp. - 5.12 4.48 2.86 2.63 1.39 1.19 1.17 1.40 1.67 1.39 % Of Sales - 0.23% 0.23% 0.15% 0.16% 0.14% 0.17% 0.20% 0.36% 0.30% 0.29% Selling & Distn. Exp. - 66.84 50.78 48.45 46.72 33.73 20.81 12.81 6.39 11.27 0.00 % Of Sales - 3.06% 2.58% 2.56% 2.77% 3.43% 2.93% 2.21% 1.66% 2.00% 0% Miscellaneous Exp. - 28.93 21.90 13.58 11.03 9.04 11.65 8.33 8.48 6.47 0.00 % Of Sales - 1.32% 1.11% 0.72% 0.65% 0.92% 1.64% 1.44% 2.20% 1.15% 3.26% EBITDA 173.85 256.28 591.84 573.88 409.65 119.53 102.20 51.38 11.27 95.75 89.04 EBITDA Margin 7.89% 11.73% 30.09% 30.29% 24.31% 12.16% 14.38% 8.85% 2.93% 16.99% 18.49% Other Income 23.78 32.04 24.30 16.02 10.37 6.33 1.25 1.23 1.32 1.31 2.53 Interest 13.93 8.29 5.83 20.93 51.42 64.35 67.68 61.47 59.11 60.34 57.24 Depreciation 45.04 43.26 38.92 35.73 32.45 30.21 29.84 29.69 28.91 31.63 31.37 PBT 138.66 236.77 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 5.08 2.96 Tax 36.20 57.18 126.83 171.95 99.45 3.60 1.26 1.48 -8.79 1.78 1.37 Tax Rate 26.11% 25.66% 22.20% 32.25% 29.59% 11.50% 21.25% -3.84% 11.65% 35.04% 46.28% PAT 102.46 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 3.30 1.59 PAT before Minority Interest 102.46 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 -66.65 3.30 1.59 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.65% 7.59% 22.60% 19.07% 14.04% 2.82% 0.66% -6.90% -17.32% 0.59% 0.33% PAT Growth -51.93% -62.74% 23.05% 52.64% 754.51% 493.15% - - - 107.55% EPS 17.45 28.22 75.73 61.55 40.32 4.72 0.80 -6.82 -11.35 0.56 0.27

Description TTM Mar 22
Net Sales - 2,184.02 Net Sales Growth - Cost Of Goods Sold - 1,570.51 Gross Profit - 613.51 GP Margin - 28.09% Total Expenditure - 1,925.73 Power & Fuel Cost - 78.18 % Of Sales - 3.58% Employee Cost - 141.30 % Of Sales - 6.47% Manufacturing Exp. - 36.86 % Of Sales - 1.69% General & Admin Exp. - 5.12 % Of Sales - 0.23% Selling & Distn. Exp. - 66.84 % Of Sales - 3.06% Miscellaneous Exp. - 26.92 % Of Sales - 1.23% EBITDA - 258.29 EBITDA Margin - 11.83% Other Income - 32.04 Interest - 8.29 Depreciation - 43.26 PBT - 238.78 Tax - 57.18 Tax Rate - 25.43% PAT - 167.67 PAT before Minority Interest - 167.67 Minority Interest - 0.00 PAT Margin - 7.68% PAT Growth - EPS - 28.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 1,390.27 1,260.43 813.54 474.34 215.74 188.70 185.13 207.20 209.25 172.99 Share Capital 58.71 58.71 56.89 56.89 56.21 56.21 56.21 47.66 48.83 31.15 Total Reserves 1,331.56 1,201.72 747.33 408.13 159.53 132.49 128.92 153.56 160.42 141.84 Non-Current Liabilities 56.62 59.11 79.73 210.65 280.29 294.23 304.43 285.87 255.48 325.73 Secured Loans 0.00 0.00 0.00 189.88 236.16 262.37 283.25 253.84 163.91 202.96 Unsecured Loans 0.00 0.00 0.00 0.00 21.96 22.61 18.62 23.26 56.50 83.88 Long Term Provisions 3.01 3.68 3.85 4.59 2.04 1.50 1.18 0.30 0.30 0.13 Current Liabilities 575.29 432.80 453.63 324.79 350.97 327.67 282.92 208.54 276.82 228.54 Trade Payables 409.29 238.83 180.38 120.27 157.61 149.84 115.68 70.25 120.36 95.38 Other Current Liabilities 54.02 41.00 34.46 63.88 50.97 35.84 30.03 17.81 58.57 35.46 Short Term Borrowings 42.75 0.00 55.92 67.72 135.27 140.77 137.09 120.44 96.96 97.16 Short Term Provisions 69.23 152.97 182.87 72.92 7.12 1.22 0.13 0.04 0.94 0.54 Total Liabilities 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.48 701.61 741.55 727.26 Net Block 560.64 512.36 469.04 411.72 405.64 373.88 399.50 402.82 410.60 430.41 Gross Block 762.84 677.69 595.78 503.91 465.53 403.77 619.96 594.29 569.47 557.84 Accumulated Depreciation 202.20 165.33 126.74 92.19 59.89 29.89 220.47 191.47 158.86 127.42 Non Current Assets 881.58 600.19 498.99 457.60 416.02 395.94 415.63 418.12 460.38 475.91 Capital Work in Progress 105.20 48.27 19.19 27.02 6.95 21.26 4.31 4.21 33.06 31.51 Non Current Investment 0.10 0.00 0.00 0.00 0.00 0.05 0.04 0.04 0.00 0.00 Long Term Loans & Adv. 10.77 17.61 1.33 11.56 1.26 0.38 9.01 10.75 13.08 11.92 Other Non Current Assets 204.87 21.95 9.43 7.30 2.17 0.37 2.77 0.30 3.63 2.07 Current Assets 1,140.60 1,152.15 847.91 552.18 430.98 414.66 356.86 283.49 281.17 251.35 Current Investments 2.37 1.22 0.05 0.06 0.06 0.05 0.05 0.01 0.00 0.00 Inventories 409.89 295.15 187.52 188.86 207.45 262.63 227.94 213.42 192.23 163.47 Sundry Debtors 469.80 300.31 272.42 199.16 146.14 112.77 87.26 32.67 49.26 35.82 Cash & Bank 137.88 364.74 154.65 29.60 17.32 16.81 11.94 12.70 11.45 12.39 Other Current Assets 120.66 38.52 24.40 7.62 60.01 22.40 29.67 24.68 28.25 39.66 Short Term Loans & Adv. 89.67 152.21 208.87 126.88 56.79 18.79 26.78 22.19 25.37 36.98 Net Current Assets 565.31 719.35 394.28 227.39 80.01 86.99 73.93 74.95 4.35 22.82 Total Assets 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.49 701.61 741.55 727.26

Description Mar 22
Shareholder's Funds 1,392.28 Share Capital 58.71 Total Reserves 1,333.57 Non-Current Liabilities 56.62 Secured Loans 0.00 Unsecured Loans 0.00 Long Term Provisions 3.01 Current Liabilities 575.29 Trade Payables 409.29 Other Current Liabilities 54.02 Short Term Borrowings 42.75 Short Term Provisions 69.23 Total Liabilities 2,024.19 Net Block 560.64 Gross Block 762.84 Accumulated Depreciation 202.20 Non Current Assets 881.48 Capital Work in Progress 105.20 Non Current Investment 0.00 Long Term Loans & Adv. 6.14 Other Non Current Assets 209.50 Current Assets 1,142.71 Current Investments 2.37 Inventories 409.89 Sundry Debtors 469.80 Cash & Bank 139.99 Other Current Assets 120.66 Short Term Loans & Adv. 89.67 Net Current Assets 567.42 Total Assets 2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 91.04 379.78 470.80 273.17 119.72 83.34 17.70 -46.96 78.40 53.19 PBT 222.84 571.39 533.24 336.15 31.30 5.93 -38.55 -75.44 5.08 2.96 Adjustment 33.12 27.15 51.93 82.35 91.64 95.92 83.92 81.73 86.38 83.25 Changes in Working Capital -102.34 -76.51 2.78 -77.64 3.14 -17.45 -27.67 -52.83 -12.31 -32.25 Cash after chg. in Working capital 153.62 522.03 587.95 340.86 126.08 84.40 17.70 -46.54 79.15 53.96 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -62.58 -142.25 -117.15 -67.69 -6.36 -1.06 0.00 -0.42 -0.75 -0.76 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -120.29 -317.25 -184.23 -63.04 -50.38 -22.78 -27.37 -4.79 -12.12 -17.97 Net Fixed Assets -142.08 -110.99 -84.04 -58.45 -47.45 199.24 -25.77 4.03 -13.18 -17.98 Net Investments -1.25 -1.17 0.01 0.00 0.04 -0.01 -0.04 -0.05 0.00 0.00 Others 23.04 -205.09 -100.20 -4.59 -2.97 -222.01 -1.56 -8.77 1.06 0.01 Cash from Financing Activity -1.64 -58.28 -271.89 -197.46 -70.36 -59.78 9.27 49.69 -65.68 -31.80 Net Cash Inflow / Outflow -30.89 4.25 14.68 12.67 -1.02 0.78 -0.40 -2.07 0.60 3.42 Opening Cash & Equivalents 32.34 28.09 13.41 0.74 1.76 0.98 1.38 15.06 14.46 11.03 Closing Cash & Equivalent 1.45 32.34 28.09 13.41 0.74 1.76 0.98 12.99 15.06 14.46

Description Mar 22
Cash From Operating Activity 93.05 PBT 224.85 Adjustment 33.12 Changes in Working Capital -102.34 Cash after chg. in Working capital 155.63 Interest Paid 0.00 Tax Paid -62.58 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -120.19 Net Fixed Assets Net Investments Others Cash from Financing Activity -1.64 Net Cash Inflow / Outflow -28.78 Opening Cash & Equivalents 32.34 Closing Cash & Equivalent 3.56

Financial Ratios

Standalone /

Consolidated

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 236.80 214.69 141.36 81.74 38.38 33.57 32.94 42.22 65.67 64.24 ROA 8.78% 28.69% 30.66% 25.50% 3.34% 0.59% -5.43% -9.24% 0.45% 0.22% ROE 12.50% 43.06% 56.93% 69.54% 13.70% 2.50% -20.72% -34.14% 1.85% 0.95% ROCE 17.16% 54.20% 68.09% 55.53% 15.03% 11.57% 3.68% -2.78% 11.48% 10.55% Fixed Asset Turnover 3.03 3.09 3.45 3.48 2.30 1.51 1.06 0.73 1.11 0.96 Receivable days 64.35 53.14 45.43 37.39 47.21 47.21 33.98 35.12 24.85 19.63 Inventory Days 58.91 44.78 36.26 42.92 85.71 115.79 125.04 173.90 103.91 100.92 Payable days 75.31 69.37 41.74 37.73 62.92 46.31 3.40 9.79 8.96 18.14 Cash Conversion Cycle 47.95 28.55 39.95 42.57 69.99 116.69 155.61 199.24 119.80 102.41 Total Debt/Equity 0.03 0.00 0.07 0.61 1.96 2.37 2.44 1.99 1.71 2.31 Interest Cover 27.88 99.01 26.48 7.54 1.49 1.09 0.37 -0.28 1.08 1.05

Description Mar 22
Book Value (Rs.) 237.15 ROA 8.28% ROE 12.04% ROCE 16.25% Fixed Asset Turnover 2.86 Receivable days 78.51 Inventory Days 68.50 Payable days 95.12 Cash Conversion Cycle 51.89 Total Debt/Equity 0.03 Interest Cover 28.12

Top Investors:

vasudeva commercials limited

trichit limited

enorg limited

ashish kacholia

g consultants and fabricators ltd

pinebridge global funds - pinebridge india equity fund

Annual Reports:

News Update:

IOL Chemicals and Pharmaceuticals reports 40% fall in Q3 net profit
8th Feb 2023, 14:07 PM

Total income of the company decreased 6.01% at Rs 530.12 crore for Q3FY23
Read More
IOL Chem & Pharma - Quarterly Results
7th Feb 2023, 17:49 PM

Read More
IOL Chemicals and Pharmaceuticals incorporates wholly owned subsidiary in UK
1st Feb 2023, 15:17 PM

The WOS is incorporated to carry on the business in the field of Pharmaceuticals/Chemicals
Read More

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 524164 | NSE: IOLCP

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

BSE: 524164 | NSE: IOLCP

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: